ACTRN12609000799257已完成未知
In patients with type 2 diabetes mellitus who are sedentary, are aerobic exercise or resistance exercise, different to no exercise (stretching only) in causing change in endothelial function and insulin sensitivity?
Baker IDI Heart and Diabetes Institute0 个研究点目标入组 45 人开始时间: 2009年9月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 20 Years 至 70 Years(—)
- 性别
- All
入选标准
- •People with established type 2 diabetes (duration > 6 months), treated with diet or oral antihyperglycaemic agents, as monotherapy, dual or triple therapy with metformin, sitagliptin, glitazone or acarbose; (no more than 3 oral agents; stable dose for = 8 weeks), with stable weight over the previous 3 months (< 5% change in body weight), stable glycaemic control for at least the past 8 weeks (no changes to diabetes medication), HbA1c greater or equal to 6.5% and less than or equal to 9.9%.
排除标准
- •Exceeding the national recommendations for exercise which are at least 30 mins of moderate-intensity aerobic activity on 5 days of the weeks for at least 3 months and/or at least 20 mins of vigorous-intensity aerobic activity on 3 days of the week for at least 3 mths (60 mins per week). Any strength trainig for 2 or more sessions per week in last 3 months is an exclusion. Body mass index <18.0 or >40.0, seated resting blood pressure > 160 mm Hg systolic of > 95 mm Hg diastolic, pregnancy, anticipated requirement for medications affecting glucose tolerance during trial, renal disease or kidney failure, current smoker, taking medication to lower heart rate (beta blockers), unable to commit to completing the entire protocol, language other than English, known physical activity contraindications, other illness/injury (acute or chronic) leading to physical or medical problems that may limit the ability to perfom the necessary exercise.
研究者
相似试验
尚未招募
4 期
Molecular determinants of glucose sensing in human gastrointestinal tract of patients with type 2 diabetes and healthy volunteers.Type II DiabetesMetabolic and Endocrine - DiabetesACTRN12613000843752Dr. Nam Q Nguyen40
已完成
3 期
Double blind, randomised, comparative, multicentre, parallel-group study design to evaluate the effects of Pioglitazone on cardiovascular risk markers in type 2 diabetes mellitusACTRN12608000534381Takeda Italia Farmaceutici S.p.A.100
招募中
不适用
Structured monitoring of blood glucose for people with non-insulin-treated type 2 diabetes: Structured Testing Program Implementation Trial – Updated Protocol (STeP IT UP)Type 2 diabetes mellitus (T2DM)Metabolic and Endocrine - DiabetesACTRN12613000927729Roche Diagnostics Australia145
招募中
不适用
The role of Vitamin C in managing type 2 diabetes: Vitamin C, Thiazolidinediones and their combined effect onAdiponectiType 2 diabetesMetabolic and Endocrine - DiabetesACTRN12611000488909Princess Alexandra Hospital10
尚未招募
不适用
Townsville Diabetes Home Monitoring ProjectType II diabetesMetabolic and Endocrine - DiabetesACTRN12612000086864Townsville Mackay Medicare Local (TMML)210
